Table 4.

Associations between TLI status and OS or DFS rates of the patient subgroups

	5-year DFS rate (%)	P-value	5-year OS rate (%)	P-value
Patients with adjuvant chemotherapy (n = 205)		0.272		0.224
Low TLI	75		89
High TLI	68		80
Patients without adjuvant chemotherapy (n = 63)		0.663		0.634
Low TLI	83		95
High TLI	89		96
Patients with adjuvant hormonal therapy(n = 187)		0.512		0.824
Low TLI	79		89
High TLI	78		89
Patients without adjuvant hormonal therapy (n = 81)		0.933		0.164
Low TLI	69.4		88.9
High TLI	63.5		74.4
Patients with stage I (n = 54)		0.474		0.05
Low TLI	88.2		100
High TLI	78.7		76.4
Patients with stage II (n = 138)		0.464		0.070
Low TLI	79.8		95.4
High TLI	74.2		89.7
Patients with stage III (n = 76)		0.526		0.800
Low TLI	65.7		76.3
High TLI	63.2		73.4
Patients with node-negative disease (n = 114)		0.994		0.188
Low TLI	83.5		92.6
High TLI	86.1		88.6
Patients with node-positive disease (n = 154)		0.142		0.113
Low TLI	72.6		86.4
High TLI	61.2		73.6